1.. Introduction {#S1}
================

There are about 100 trillion (10^14^) microorganisms and approximately 2000 different bacterial species in the human digestive tract.^[@R1]^ The gut microbiota colonizes immediately after birth and plays an essential role in keeping the host healthy by assisting digestion, producing vitamins, generating bile acids, and modulating local and systemic immunity.^[@R2]--[@R5]^ Many factors, including diet, age, medication, illness, stress, and lifestyle, influence the gut microbiota community structure, which has an impact on disease development.^[@R6]^ It is important to note that genetic factors only contribute to 5--15% of most cancers. About 80% of cancers are caused by the environment or lifestyle.^[@R7]^ Emerging evidence reveals that the gut microbiota is a major environmental and etiological factor for liver disease development.^[@R8]--[@R12]^ In this review, we summarize publications on the topics of gut microbiota in liver disease development, as well as treatment, focusing on non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma (HCC).

We performed a literature search in PubMed for papers published within the past 10 years, using the keywords: microorganism, microbiota, bacteria, liver, liver disease, HCC, hepatocellular carcinogenesis, NAFLD, NASH, cirrhosis, probiotics, prebiotics, synbiotics, and their combinations.

2.. Role of gut microbiota in liver diseases {#S2}
============================================

2.1.. Gut microbiota and NAFLD as well as NASH {#S3}
----------------------------------------------

NAFLD is a global public health problem because of the prevalence of obesity.^[@R13]^ NAFLD is a spectrum of chronic liver diseases, including simple steatosis, NASH, advanced fibrosis, cirrhosis, and HCC.^[@R6]^ Dysbiosis refers to unfavorable alteration of the microbiota. It is commonly characterized with a decreased ratio of autochthonous to nonautochthonous taxa. Increasing evidence indicates that gut dysbiosis has an important role in the development of NASH via regulation of inflammation, insulin resistance, bile acids, and choline metabolism.^[@R4],[@R14]--[@R16]^

Data generated from human studies have established the relationship between gut microbiota and NAFLD ([Table 1](#T1){ref-type="table"}).^[@R14],[@R17]--[@R24]^ In, 2013, Mouzaki *et al.*^[@R17]^ reported that NASH patients have significantly lower levels of Bacteroidetes compared to healthy individuals. Shen et *al.*^[@R18]^ showed similar findings. However, Wang *et al.*^[@R19]^ found that non-obese patients with NAFLD have significantly higher levels of Bacteroidetes and lower abundance of Firmicutes in addition to reduced diversity. In these non-obese patients with NAFLD, the depletion of Firmicutes included Lachnospiraceae, Ruminococcaceae, and Lactobacillaceae, which generated short-chain fatty acids (SCFAs).^[@R19]^ Additionally, a different Bacteroidetes abundance pattern in adolescents was revealed in a study conducted by Stanislawski et *al.*^[@R20]^ The abundance of *Bacteroides* showed a U-shaped pattern based on hepatic fat; both low and high abundances were associated with elevated hepatic fat, while a moderate level was associated with reduced hepatic fat.^[@R20]^ In addition, *Bacteroides* is associated with a high-fat diet (HFD).^[@R25]^ However, certain species of *Bacteroides* have protective roles in obesity.^[@R26]^

Stanislawski *et al.*^[@R20]^ also found that *Bilophila, Paraprevotella, Suturella*, and *RF32* have a positive relationship with hepatic fat, while *Oscillospira* and *Varibaculum* correlate negatively. The positive association between hepatic fat and *Bilophila* is accompanied by reduced *Oscillospira.* These results suggest that *Bilophila* might contribute to fatty liver, while *Oscillospira* might counteract its effects.^[@R21]^ The abundance of *Bilophila wadworthia* increases in response to a western diet or HFD.^[@R27],[@R28]^ *Bilophila wadworthia* is also associated with T helper 1 (Thl)-mediated intestinal inflammation. *Oscillospira* is reduced in pediatric NAFLD and NASH.^[@R21],[@R22]^ Reduced *Oscillospira* accompanied by increased 2-butanone has been identified as a gut microbiota signature of NAFLD onset. Increases in *Ruminococcus* and *Dorea* have been identified as gut microbiota signatures of NAFLD and NASH progression.^[@R21]^ *Oscillospira* is generally linked to leanness and health.^[@R23]^ *Bilophila, Oscillospira,* and *Bacteroides* are associated with diets high in animal products.^[@R29]--[@R31]^ In addition, increased levels of *Lactobacillus* and selected members of the Firmicutes (Lachnospiraceae; genera, *Dorea, Robinsoniella,* and *Roseburia*) have been observed in NAFLD patients.^[@R24]^ NAFLD patients and healthy subjects have a distinct intestinal microbiota community structure.

Further evidence shows that gut dysbiosis and altered metabolic function are linked with the severity of NAFLD. A study by Boursier *et al.*^[@R14]^ demonstrated that *Bacteroides* and *Ruminococcus* are associated with NASH and the severity of fibrosis. Patients with NASH and fibrosis severity F ≥ 2 have higher abundance of *Bacteroides* and lower abundance of *Prevotella* compared to those without NASH. Patients with F ≥ 2 fibrosis have higher abundance of *Bacteroides* and *Ruminococcus* and lower abundance of *Prevotella* compared with those with F0/F1 fibrosis.^[@R14]^ Patients with mild/moderate NAFLD have a higher abundance of Firmicutes, while patients with advanced fibrosis NAFLD have a higher abundance of Proteobacteria. Patients with advanced fibrosis have lower abundance of *Ruminococcus obeum* CAG: 39, *Ruminococcus obeum,* and *Eubacterium rectale* compared to those with mild/moderate NAFLD.^[@R32]^

Small intestinal bacterial overgrowth (SIBO) is defined as bacterial culture \>10^5^ CFU/ml in upper jejunal aspirate.^[@R33],[@R34]^ SIBO has a direct relationship with the severity of liver disease. Many patients with chronic liver disease have dysbiosis with SIBO.^[@R3],[@R35]^ SIBO in patients with NAFLD/NASH has an estimated prevalence of 39--85%.^[@R36]--[@R41]^ As a consequence of reduced intestinal motility and decreased bile acid production, SIBO has a role in NAFLD progression.^[@R42]^ Miele *et al.*^[@R37]^ have reported that SIBO is implicated in increased intestinal permeability and development of fatty liver. SIBO increases lipopolysaccharide (LPS) secretion and inflammation. Hepatic expression of Toll-like receptor 4 (TLR4), together with release of interleukin-8 (IL-8) induced by SIBO, promotes inflammation.^[@R4]^ SIBO increases endogenous ethanol and intestinal permeability, favoring LPS production and increased inflammation via TLR4 signaling.^[@R43],[@R44]^ SIBO is considered as an independent risk factor for the severity of NAFLD and is essential for NAFLD to progress into NASH, followed by development of cirrhosis.^[@R15],[@R19],[@R38],[@R45],[@R46]^

Enteric dysbiosis or intestinal inflammation induced by HFD and dextran sulfate sodium significantly promotes liver fibrosis in mice with NASH.^[@R47]^ The inflammasome-mediated dysbiosis, including increased Prevotellaceae and Porphyromonadaceae families as well as the TM7 taxa, promote NAFLD progression in mouse models.^[@R6]^ Apart from providing bacterial byproducts and increasing intestinal permeability, the gut microbiota might also inhibit small intestinal secretion of fasting-induced adipocyte factor, resulting in increased hepatic triglyceride deposition.^[@R48]^ Antibiotic treatment or surgical removal of the bypassed section of the intestine can reverse SIBO and steatohepatitis.^[@R36],[@R42]^ SIBO might be an important target for using antibiotics in treating NAFLD as well as NASH.^[@R49],[@R50]^

Patients with liver cirrhosis and liver or colon cancer have reduced bile acid receptor farnesoid X receptor (FXR).^[@R51]--[@R53]^ Wan's group has shown that the sex of an animal can affect the gut microbiota, which is implicated in the dissimilar development of steatosis in both western-diet-fed mice and FXR knockout (KO) mouse models according to sex.^[@R54]^ Decreased S24--7, in parallel with increased Bacteroidaceae, Rikeneilaceae, Lactobacillaceae, and Verrucomicrobiaceae, has been observed in wild-type female mice compared to their male counterparts. However, these sex differences are abolished in FXR KO mice, indicating that sex difference in steatosis is FXR dependent.^[@R54]^ Western-diet-fed male FXR KO mice develop advanced NASH with massive hepatic lymphocyte infiltration, and have decreased Firmicutes and increased Proteo-bacteria.^[@R55]^ Broad-spectrum as well as a Gram-negative coverage antibiotics are useful in treating NASH in male FXR KO mice, but are relatively ineffective when FXR K0 male mice are on a western diet.^[@R55]^ In the Proteobacteria, the relative abundance of Heli-cobacteraceae and Desulfovibrionaceae substantially increases because of FXR inactivation. Consistently, antibiotic-reduced hepatic inflammation is accompanied by their reduction. In contrast, *Lactococcus, Lactobacillus,* and *Coprococcus* have a protective effect in hepatic inflammation.^[@R55]^ The basic mechanisms of dysbiosis affecting liver disease are summarized in [Fig. 1](#F1){ref-type="fig"}.

2.2.. Gut microbiota and liver cirrhosis as well as cirrhosis-associated complications {#S4}
--------------------------------------------------------------------------------------

### 2.2.1.. Gut microbiota and liver cirrhosis {#S5}

Liver cirrhosis is the end stage of chronic liver diseases and is characterized by fibrosis, abnormal hepatic architecture, and portal hypertension. Liver cirrhosis may lead to progressive hepatic failure and cancer. It has been shown that dysbiosis can affect clinical outcomes, including 90-day-hospitalization, organ failure, and death.^[@R56]--[@R58]^

Cirrhosis-associated gut dysbiosis is accompanied by reduced Bacteroidetes, increased Proteobacteria at the phylum level, and reduced Lachnospiraceae as well as increased Enterobacteriaceae and Veillonelaceae at the family level^[@R5]^. Potentially pathogenic overgrowth of Enterobacteriaceae is linked to the severity of cirrhosis and its complications, such as hepatic encephalopathy.^[@R5]^ Chen *et al.*^[@R59]^ demonstrated an increase in Proteobacteria and Fusobacteria, along with a decrease in Bacteroidetes and change in Firmicutes at the phylum level in fecal samples from cirrhotic patients. In addition, cirrhotic patients have increased fecal Entero-bacteriaceae, Veillonelaceae, and Streptococcaceae, and reduced Lachnospiraceae.^[@R59]^ Moreover, several commensal genera, such as, *Coprococcus, Pseudobutyrivibrio,* and *Roseburia* in the Lachnospiraceae family, are beneficial to the host via production of SCFAs.^[@R59]^

In 2014, Bajaj *et al*.^[@R56]^ compared fecal microbiota analysis in cirrhotic patients and healthy controls. They reported that the reduction of autochthonous taxa, including Lachnospiraceae, Ruminococcaceae, and Clostridiales XIV, and increase of non-autochthonous taxa including Staphylococcaceae, Enter-ococcaceae, and Enterobacteriaceae, are linked to liver failure and plasma LPS levels in cirrhosis patients. In addition, Enterobacteriaceae and endotoxemia are enriched in patients with alcoholic compared with non-alcoholic cirrhosis.^[@R56]^ Enterobacteriaceae are also frequently found in spontaneous bacterial peritonitis; an infection in decompensated cirrhosis.^[@R60]^ Enterobacteriaceae are more abundant in patients with decompensated cirrhosis compared to patients with compensated cirrhosis and healthy controls.^[@R51]^ The mucosal microbiota in the duodenum also differs markedly between cirrhotic patients and healthy controls.^[@R34]^ Based on the predicted metagenomes analyzed, pathways related to nutrient absorption are enriched in the duodenal microbiota of patients with cirrhosis, while bacterial proliferation and colonization, including bacterial motility proteins and secretory systems, are over-represented in control subjects.^[@R34]^

Bile acid pool size and composition are major regulators of microbiome structure.^[@R61],[@R62]^ Increased primary bile acid, cholic acid (CA) can cause dysbiosis with a dramatic shift toward the Firmicutes, particularly *Clostridium* cluster XlVa and can increase production of deoxycholic acid (DCA).^[@R61],[@R62]^ Cirrhosis-associated dysbiosis increases inflammation via metabolism, LPS, and translocation. Inflammation can suppress synthesis of bile acids in the liver.^[@R61],[@R62]^ Secondary bile acids, which are generated by the Clostridiales cluster, are reduced in cirrhotic patients.^[@R63],[@R64]^ Bile acids have an important role in the pathogenesis of cirrhosis,^[@R54],[@R55],[@R65]^ Reduced bile acid secretion facilitates oral microbiota migration to the distal gut and boosts SIBO. In contrast, activation of FXR stimulates bile acid excretion and induces production of antimicrobial peptides.^[@R66],[@R67]^ The interaction between bile acids and microbiota plays an important role in cirrhosis.^[@R61],[@R62]^ The data related to alteration of gut microbiota in cirrhotic patients are summarized in [Table 2](#T2){ref-type="table"}.^[@R34],[@R56],[@R57],[@R59],[@R64]^

### 2.2.2.. Gut microbiota and complications associated with liver cirrhosis {#S6}

Bacterial translocation (BT) plays a crucial role in the development of complications associated with hepatic cirrhosis.^[@R68]^ By inoculating an equal amount of *Escherichia coli* (*E. coli*) into small and large intestines, it was found that BT predominantly occurs in the small intestine.^[@R69]^ Consistently, the small intestine is a preferred site for BT in cirrhotic patients.^[@R70]^ In addition, BT is closely associated with SIBO as well as intestinal barrier injury in cirrhotic rats.^[@R71]^

Spontaneous bacterial peritonitis is a common complication of liver cirrhosis because bacterial infections occur in cirrhotic patients with ascites.^[@R72]--[@R74]^ Most of the bacteria in patients with spontaneous bacterial peritonitis are *E. coli, Klebsiella pneumoniae*, coagulase-negative *Staphylococcus,* and *Enterococcus.*^[@R74]^ *E. coli* is the predominant pathogen of spontaneous bacterial peritonitis. ^[@R72]--[@R74]^

Hepatic encephalopathy is a common complication of liver cirrhosis and a result of liver failure.^[@R75],[@R76]^ Hepatic encephalopathy affects brain astrocytes, microglia, and neurons.^[@R75],[@R76]^ A decrease in autochthonous bacteria and increase in Gram-negative bacteria are observed in cirrhotic patients with hepatic encephalopathy. It has been shown that elevated serum ammonia levels are linked to astrocytic impairment^[@R77]^ Moreover, ammonia-associated brain magnetic resonance imaging changes are associated with autochthonous taxa and *Enterobacteriaceae,* while white matter inflammatory changes are associated with oral taxa such as Porphyromonadaceae.^[@R77]^ Only mucosal and not fecal microbiota is altered significantly in patients with hepatic encephalopathy. The Firmicutes phylum, including *Veillonella, Megasphaera, Bifidobacterium*,.and *Enterococcus*, is highly enriched in hepatic encephalopathy, whereas *Roseburia* is more abundant in the non-hepatic encephalopathy group.^[@R73]^

### 2.2.3.. Gut microbiota and liver transplantation {#S7}

Liver transplantation is one option used to treat cirrhosis or cirrhosis-associated complications,^[@R78],[@R79].^ Liver transplantation affects the recipient's microbiota ([Table 3](#T3){ref-type="table"}).^[@R79]--[@R81]^ Gut microbiota diversity is increased after liver transplantation, but does not reach the levels in healthy controls.^[@R80]^ Alteration of Proteobacteria and Firmicutes links with improved cognitive level of patients with liver transplantation.^[@R80]^ In 2016, the Wan laboratory established the relationship between intestinal microbiota and expression of hepatic genes in regenerating the liver, using partial hepatectomy mouse models.^[@R82]^ Removal of two-thirds of mouse liver led to rapid changes in gut microbiota, with increased Bacteroidetes S24--7 and Rikenellaceae as well as decreased Firmicutes Clostridiales, Lach-nospiraceae, and Ruminococcaceae.^[@R82]^ The abundance of Rumino coccacea, Lachnospiraceae, and S24--7 was closely linked with liver metabolism and immune functions.^[@R82]^ Hepatic secondary bile acids are positively correlated with Firmicutes and negatively with Bacteroidetes, while tauro-conjugated bile acids show positive correlations with Bacteroidetes and negative correlations with Firmicutes.^[@R82]^ Priming mice with all-trans retinoic acid lowers the ratio of Firmicutes to Bacteroidetes and increases hydrophilic bile acids, which is linked with facilitated metabolism and enhanced cell proliferation in regenerating mouse livers.^[@R83]^

Bajaj *et al.*^[@R81]^ have reported the effect of liver transplantation on microbial composition and functionality in patients. Successful liver transplantation increases the microbial diversity accompanied by an increase in autochthonous and a decrease in potentially pathogenic taxa.^[@R81]^ The favorable changes in the gut microbiota also have the benefit of increasing fecal bile acids and urinary phenyl-acetylglutamine, accompanied with a reduction in serum ammonia and endotoxemia.^[@R81]^

### 2.2.4.. Fungal dysbiosis and complications associated with liver cirrhosis {#S8}

In addition to bacteria, microbiota includes archaea, protists, fungi, viruses, and bacteriophages.^[@R84]^ A recent study showed fungal dysbiosis in cirrhotic patients. Bajaj *et al.*^[@R85]^ have demonstrated a link between fungal and bacterial diversity in patients with liver cirrhosis, and Bacteroidetes/Ascomycota ratio can affect 90-day-hospitalization ([Table 4](#T4){ref-type="table"}). Moreover, *Candida* overgrowth and reduced intestinal fungal diversity are observed in patients with alcoholic cirrhosis ([Table 4](#T4){ref-type="table"}).^[@R86]^

### 2.2.5.. Oral microbiota and liver cirrhosis {#S9}

Oral microbiota contributes to the progression of liver diseases. Elevated oral *Streptococcus* and *Veillonella* are found in cirrhotic patients.^[@R87]^ Increased Enterobacteriaceae and Enterococcaceae, as well as reduced autochthonous bacteria, are found in patients with previous episodes of hepatic encephalopathy.^[@R87]^ Oral microbiota has a significant impact on duodenal microbiota. At the genus level, the most distinctive taxa found in cirrhotic patients and controls include *Veillonella, Prevotella, Neisseria,* and *Haemophilus,* which are commonly found in the oral cavity.^[@R88]^

Bajaj *et al.*^[@R89]^ performed a direct comparison of the salivary microbiome between healthy controls and patients with cirrhosis. Relative abundance of potentially pathogenic taxa (*Prevotella* and Fusobacteriaceae) increased whereas autochthonous taxa (Lach-nospiraceae and Ruminococcaceae) decreased in oral microbiota of cirrhotic patients with previous hepatic encephalopathy.^[@R83]^ Mi-crobes of oral origin can be present in the duodenum. Duodenal *Prevotella* and *Fusobacterium* are also increased significantly in, cirrhotic patients.^[@R34]^ Proton pump inhibitors increase the microbiota of oral origin in patients with cirrhosis.^[@R90]^ The removed pH barrier in the gastrointestinal tract allows the microbiota of oral origin to migrate along the gastrointestinal tract and even into feces.^[@R90]^ Certain oral bacteria can produce high levels of hydrogen sulfide (H~2~S) and methyl mercaptan (CH~3~SH).^[@R91]^ Higher proportions of *Neisseria, Porphyromonas,* and *SRI* are linked to H~2~S production that can damage deoxyribonucleic acid (DNA). *Prevotella, Veillonella, Atopobium, Megasphaera,* and *Selenomonas* are associated with production of CH~3~SH, which contributes to development of hepatic encephalopathy.^[@R91],[@R92]^ Literature related to oral microbiota and liver disease is summarized in [Table 5](#T5){ref-type="table"}.^[@R34],[@R87],[@R89],[@R90]^

2.3.. Gut microbiota and HCC {#S10}
----------------------------

Gut microbes are implicated in liver carcinogenesis.^[@R5],[@R93],[@R94]^ *Helicobacter* species are important pathogens that may be directly involved in the occurrence of liver cancer, and are found in human HCC specimens.^[@R95]^ A human study has shown that *Helicobacter* is present in the liver of patients with primary liver carcinoma but not in controls without primary liver carcinoma.^[@R96]^ However, *Helicobacter hepaticus* (*H. hepaticus*) is not present in HCC patients with chronic hepatitis B or C.^[@R97]^

*H. hepaticus* infection promotes HCC in chemical and viral transgenic liver cancer models.^[@R98]^ However, HCV transgene or H. *hepaticus* exposure alone is not sufficient to initiate liver cancer.^[@R98]^ Moreover, increased risk of HCC is not dependent on translocation of *H. hepaticus* to the liver.^[@R98]^ Gut *H*. *hepaticus* colonization induces nuclear factor κ-light-chain-enhancer of activated B cell signaling, which activates innate and Th1-type adaptive immunity.^[@R98]^ Thus, *H. hepaticus* in the intestinal niche without translocation to the liver can change the immune signaling and play a synergistic role with chemical and viral carcinogenic factors.^[@R98]^

Gut dysbiosis is found in patients with liver cirrhosis and HCC as well as animal models using streptozotocin-HFD, diethylnitrosamine (DEN), or carbon tetrachloride (CCI~4~). Blooming of *E. coli* is found in cirrhotic patients who have HCC compared to those without HCC.^[@R99]^ In the C57BL/6J mouse model of NASH and HCC induced by streptozotocin-HFD, a significant increase of *Atopobium* spp., *Bacteroides* spp., *Bacteroides vulgatus, Bacteroides acidifaciens*, *Bacteroides uniformis, Clostridium cocleatum, Clostridium xylanolyticum,* and *Desulfovibrio* spp. is associated with disease progression.^[@R100]^ A significant reduction of *Lactobacillus, Bifidobacterium,* and *Enterococcus* species, along with increased *E. coli* and *Atopobiumcluster,* has been found in rat models of HCC induced by DEN.^[@R101]^ Moreover, *Clostridium* spp. are reduced in CCl~4~-induced liver carcinogenesis models.^[@R102]^ When DEN is used in combination with CCl~4~, gut sterilization or TLR4 deletion reduces tumor number and volume but does not affect tumor incidence, while continuous low-dose LPS administration increases tumor number and size.^[@R103]^

Changes in the microbiota of the tongue coating have been noted in patients with HCC.^[@R104]^ Moreover, enrichment of tongue *Oribacterium* and *Fusobacterium* could be microbial biomarkers of HCC.^[@R104]^ Microbial genes in the categories related to nickel/iron transport, amino acid transport, energy-producing systems, and metabolism differ in abundance between HCC patients and healthy controls.^[@R104]^

The steatohepatitis-inducing HFD (STHD-01) is a NASH-inducing HFD, which promotes HCC without chemical carcinogens.^[@R105]^ A recent study revealed that gut bacteria associated with secondary bile acid production promote STHD-01-induced HCC development that can be prevented by antibiotics.^[@R105],[@R106]^ In addition, *Prevotella* and *Oscilibacter,* producers of anti-inflammatory metabolites, can inhibit carcinogenesis. This anti-cancer effect may result from increased regulatory T (Treg) cells and reduced, migration of Thl7 cells to the liver.^[@R94]^ The gut microbiota plays a key role in HCC development and can potentially be used to treat HCC. Literature related to microbiota alteration in human HCC and animal model of HCC is summarized in [Tables 6](#T6){ref-type="table"} and [7](#T7){ref-type="table"},^[@R95]--[@R97],[@R99]--[@R102],[@R104]^ respectively.

3.. Gut microbiota-targeted therapy {#S11}
===================================

Dysbiosis contributes to the development of liver diseases. Thus, restructuring the gut microbiota community to establish eubiosis can be effective in preventing or treating liver diseases.

3.1.. Probiotics {#S12}
----------------

Probiotics are live microorganisms that provide health benefits for the host when consumed in adequate amounts.^[@R107]^ In addition to the beneficial effects on gastrointestinal diseases, probiotics also exert a beneficial effect in liver diseases.^[@R108]--[@R113]^

Li *et al.*^[@R83]^ reported that using Prohep for feeding reduces the liver tumor size in xenograft mouse models. Prohep consists of *Lactobacillus rhamnosus* (*L. rhamnosus*) GG, *E. coli* Nissle 1917, and heat-inactivated VSL\#3. Prohep feeding increases the abundance of *Prevotella* and *Oscillibacter* and generates anti-inflammatory metabolites, which lead to reduced Th17 polarization and increased differentiation of Treg/Trl cells in the gut. In addition, *L. rhamnosus* GG protects mice from high-fructose-induced NAFLD and reduces cholesterol in HFD-fed mice.^[@R114],[@R115]^ *Lactobacillus casei* shirota protects against NAFLD in multiple mouse NAFLD models via improved insulin sensitivity, reduced plasma LPS-binding protein, and inhibition of LPS/TLR4 signaling in the liver.^[@R116]--[@R118]^ Other probiotics such as *Lactobacillus plantarum* MA2, *Lactobacillus plantarum* NCU116, *Lactobacillus johnsonii* BS15, *Lactobacillus reuteri* GMNL-263, and *Lactobacillus gasseri* BNR17 also have protective roles in improving dyslipidemiaand NAFLD.^[@R119]--[@R122]^ Moreover, *Bifidobacterium* prevents fat accumulation and increases insulin sensitivity in HFD-fed rats.^[@R123]^ Probiotics of *Bifidobacterium* are superior to *Lactobacillus acidophilus* in decreasing hepatic fat accumulation.^[@R124]^

Probiotics of *Clostridium butyricum* MIYAIRI 588, a butyrate-producing bacterium, reduce hepatic lipid droplets and improve insulin sensitivity in rats with HFD-induced NAFLD.^[@R125]^ This strain also decreases hepatic lipids and LPS in rats with NAFLD induced by choline-deficient/L-amino acid-defined diet.^[@R126]^ Kumar *et al*.^[@R127]^ have demonstrated that probiotic-fermented milk and chlorophyllin significantly reduce the incidence of aflatoxin B1-associated HCC.

Although the health effects of probiotics are mainly obtained from animal studies, some consistent results have been generated in clinical studies. Administration of *L*. *rhamnosus* GG and a mixture of *Lactobacillus bulgaricus* and *Streptococcus thermophiles* has, beneficial effects on obese children with NAFLD.^[@R128],[@R129]^ VSL\#3 im, proves liver function and increases glucagon-like peptide 1 levels in obese children with NASH.^[@R130]^ Moreover, *L*. *rhamnosus* GG alters gut microbiota in patients with cirrhosis.^[@R131]^ Compared with placebo, *L. rhamnosus* GG increases the beneficial autochthonous Clostridiales Incertae Sedis XIV and Lachnospiraceae and reduces the abundance of Enterobacteriaceae and Porphyromonadaceae in patients with stable cirrhosis and minimal hepatic encephalopathy.^[@R131]^ Combination of *Bifidobacterium longum* and fructooligosaccharides (FOSs, a mixture of fermentable dietary fibers) improved minimal and overt hepatic encephalopathy in clinical studies.^[@R132],[@R133]^ In addition, VSL\#3 prevented hepatic encephalopathy in a randomized controlled clinical study.^[@R134]^ Compared with baseline, 3 months treatment with VSL\#3 increased psychometric hepatic encephalopathy scores and reduced the levels of arterial ammonia, SIBO, and orocecal transit time.^[@R134]^ Over 6 months, VSL\#3 treatment reduced the recurrence of hepatic encephalopathy in, cirrhotic patients compared with the placebo-treated controls.^[@R135]^ VSL\#3 also decreased the hepatic venous pressure gradient, cardiac index, and heart rate, and increases systemic vascular resistance and mean arterial pressure in patients with cirrhosis and ascites.^[@R136]^ This indicates that VSL\#3 improves the hepatic and systemic hemodynamics in patients with cirrhosis.^[@R136]^ A probiotics combination of eight strains of *Lactobacillus, Bifidobacterium,* and *Streptococcus,* is also effective in preventing secondary hepatic encephalopathy in patients with cirrhosis.^[@R137]^ However, in a study conducted by Solga *et al.*^[@R138]^ 4 months supplementation with VSL\#3 increased hepatic lipid content in four patients who already had steatosis. Another randomized double-blind study conducted by And reasen *et al* ^[@R139]^ revealed that 4 weeks intake of *L acidophilus* NCFM improved insulin sensitivity but did not affect systemic inflammatory response. Additionally, 6 weeks supplementation with *L acidophilus* did not change serum lipids in volunteers who had elevated cholesterol.^[@R140]^ More well-designed trials are needed to further study the effects of probiotics in preventing liver diseases.

3.2.. Prebiotics {#S13}
----------------

Prebiotics are food ingredients that selectively stimulate the growth or activity of beneficial microorganisms, such as bacteria and fungi.^[@R141],[@R142]^ They can alter the composition and/or activity of gut microbiota. Prebiotics are useful in preventing NAFLD in laboratory animals and clinical studies.^[@R109],[@R143]--[@R145]^

Prebiotics of FOSs prevent NAFLD via restoring the gut microbiota composition and intestinal epithelial barrier function, leading to reduced serum LPS, hepatic inflammation, and hepatic cholesterol content in NAFLD mice.^[@R146]--[@R148],[@R157]^ FOS supplementation significantly reduces serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in NASH patients.^[@R143]^ Lactulose increases the growth of lactic acid bacteria and *Bifidobacterium.*^[@R149]^ It also decreases serum LPS and hepatic inflammation in rats with NASH.^[@R150]^ Chitin-glucan, a prebiotic from a fungal source, reduces hepatic triglyceride, body weight gain, and glucose intolerance via restoring *clostridial* cluster XlVa in HFD-induced obese mice.^[@R151]^ Treatment with isomaltooligosaccharides plus lycopene increases adipose tissue fat mobilization, reduces body weight gain, and improves insulin sensitivity in HFD-induced NAFLD mice.^[@R152]^ Prebiotics have great potential for prevention of liver disease through improving metabolism and the intestinal barrier, as well as reducing endotoxemia.

3.3.. Synbiotics {#S14}
----------------

Synbiotics refer to the combination of probiotics and prebiotics in a form of synergism.^[@R153]^ Synbiotics that consist of *Lactobacillus paracasei* B21060 plus arabinogalactan and FOSs reduce hepatic inflammation in diet-induced NAFLD.^[@R154]^ Supplementation with seven probiotics consisting of *L*. *casei, L. rhamnosus, S. thermophilus. Bifidobacterium breve, L. acidophilus, B. longum,* and *L bulgaricus* plus FOSs improves fasting blood glucose, serum triglycerides, and inflammatory cytokines in both lean and obese NAFLD patients.^[@R155],[@R156]^ Compared to lifestyle intervention alone, synbiotics of *B. longum* plus FOSs have added benefits for NASH patients. This intervention reduces serum tumor necrosis factor *α* (TNFα), C-reactive protein, endotoxin, and AST.^[@R157]^

Milk oligosaccharides (MOs) selectively increase the growth of *Bifidobacterium infantis (B. infantis).* Synbiotics of *B. infantis* and MOs prevent occurrence of cancer-prone NASH in western-diet-fed FXR KO male mice. *B. infantis* and MOs increase G protein-coupled bile acid receptor 1 (also known as Takeda G protein-coupled receptor, TGR5)-regulated signaling, thereby generating beneficial effects. *B. infantis* and/or MO treatment also improves ileal SCFA, signaling in western-diet-fed FXR KO mice. Furthermore, MOs alone and *B. infantis* plus MOs inhibit the growth of genus *Bilophila* and reduce the abundance of bacterial genes including dissimilatory sulfite reductase (*dsrA*) and methyl coenzyme M reductase A (*mcrA*), which are increased in mice with NASH.^[@R159]^

3.4.. Other approaches {#S15}
----------------------

### 3.4.1.. Bacterial metabolite butyrate {#S16}

Butyrate is generated by bacterial fermentation of non-digestible polysaccharides.^[@R15],[@R160]^ Sodium butyrate treatment reduces inflammation and fat accumulation in diet-induced NAFLD, potentially via enriching beneficial bacteria *Christensenellaceae, Blautia*, and *Lactobacillus.*^[@R161]^ Additionally, butyrate supplementation reverses NASH via reducing hepatic β-muricholic acid (β-MCA) as well as DCA, which are implicated in the development of NASH in western-diet-fed FXR-KO mice.^[@R65],[@R69]^ It has been shown that *Lactobacillus* and *Bifidobacterium* reduce adiposity and inflammation in NAFLD rats via butyrate production and butyrate receptor G-protein-coupled receptor 109A-regulated signaling.^[@R160]^ Butyrate and its synthetic derivative, N-(l-carbamoyl-2-phenyl-ethyl) butyramide, reduce the intracellular lipid accumulation and oxidative stress in diet-induced insulin-resistant obese mice.^[@R162]^ Furthermore, sodium butyrate has a protective role in NAFLD pathogenesis via increased duodenal melatonin synthesis, as well as decreased hepatic inducible nitric oxide synthase in fructose-induced NAFLD mice.^[@R163]^

### 3.4.2.. Fecal microbiota transplantation {#S17}

A randomized clinical trial in patients with cirrhosis and recurrent hepatic encephalopathy was conducted to compare the safety of fecal microbiota transplantation with no such intervention.^[@R164]^ Fecal microbiota transplantation reduced hospitalization and improved cognition and dysbiosis in patients with cirrhosis with recurrent hepatic encephalopathy, when compared with standard of care (SOC).^[@R164]^ Fecal microbiota transplantation has protective effects in rats with CCl~4~-induced hepatic encephalopathy.^[@R165]^ Fecal microbiota transplantation reduces intestinal permeability and improves the TLR response of the liver, leading to improved cognitive function and reduced liver function indexes.^[@R165]^

### 3.4.3.. Diet {#S18}

Diet is a contributing factor to liver diseases. Fructose-enriched diet alters liver metabolism and gut barrier function, increases endotoxemia, decreases *Bifidobacterium* and *Lactobacillus,* and eventually leads to NAFLD.^[@R166]^ Long-term fructose consumption increases lipogenic enzymes via activation of sterol regulatory element binding protein-lc (SRFBPlc) and carbohydrate responsive element binding protein (ChREBP).^[@R167]^ It promotes lipogenesis, hypertriglyceridemia, hepatic insulin resistance, and hepatic steatosis.^[@R167]^ A diet rich in fermented milk, vegetables, cereals, coffee, and tea contributes to a higher microbial diversity in patients with cirrhosis.^[@R168]^ Microbial diversity is an independent factor that reduces the risk of 90-day hospitalization.^[@R168]^

4.. Conclusions and perspectives {#S19}
================================

Gut microbiota plays a pivotal role in the pathogenesis of metabolic liver diseases. Re-establishing eubiosis using probiotics, prebiotics, and synbiotics, as well as natural products, is a promising avenue to prevent and treat liver diseases and, potentially, liver cancer. Although bile acid and SCFA-regulated pathways can explain how diet through gut microbiota affects health and disease processes, other molecular links remain to be uncovered. With the advancement of sequencing technology as well as cultural techniques, specific bacterial species and microbial functions can be uncovered to establish a causal relationship. There is no doubt that metabolomics and epigenetic genomics are powerful tools to elucidate the underlying mechanism for disease processes, leading to innovative treatment strategies. The generated information should have an impact on personalized nutrition as well as precision medicine.
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![The mechanisms by which gut microbiota affects liver health and diseases.\
Under healthy condition, intestinal barrier and integrity prevent the entry of bacterial products, such as endotoxin, from the gut into the portal circulation. Liver immune cells rapidly clear the microbial products and bacteria passing though the gut barrier, thereby establishing immune tolerance without inflammation, Gut microbiota contributes to improving insulin sensitivity, reducing inflammation, and hepatic lipid accumulation via modulating the productions of bile acids, short-chain fatty acids, glucagon-like peptide 1, etc. Factors such as antibiotics, injury, infection, and high-fat diet can cause dysbiosis. Dysbiosis increases endogenous ethanol, endotoxin, and intestinal permeability, thereby leading the translocations of bacteria and bacterial metabolites from the intestine to the liver. Bacteria and their metabolites can activate the innate immune system via toll-like receptors and cause inflammation and subsequent liver damage. Moreover, dysbiosis-associated bile acid dysregulation increases insulin resistance, hepatic lipid accumulation, and inflammatory signaling. Furthermore, dysbiosis converts choling to trimethylamine, Which leads to choline deficiency. All these metabolites and factors contribute to liver diseases. Abbreviations: NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; TLRs, Toll-like receptors.](nihms-1031443-f0001){#F1}

###### 

Gut microbiota alteration in NAFLD and NASH patients.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors                         Population                                                                           *N*   Comparison                                       Implicated microbiota                                                   Methodology                                                                                                                                                                                                  
  ------------------------------- ------------------------------------------------------------------------------------ ----- ------------------------------------------------ ----------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------
  Boursier *et al*.^[@R14]^       F0/F1 fibrosis without NASH\                                                         20\   NASH *vs* no NASH                                Bacteroidetes\                                                          Bacteroidaceae[↑](#TFN2){ref-type="table-fn"}\                                                       *Bacteroides*[↑](#TFN2){ref-type="table-fn"}\                                                           16S rRNA gene sequencing (Stool sample)
                                  \                                                                                    \                                                      \                                                                       \                                                                                                    \                                                                                                       
                                  F0/F1 fibrosis with NASH                                                             10                                                     Bacteroidetes                                                           Prevotellaceae [↓](#TFN3){ref-type="table-fn"}                                                       *Prevotella*[↓](#TFN3){ref-type="table-fn"}                                                             

                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

                                  F ≥ 2 fibrosis without NASH\                                                         2\    F ≥ 2 fibrosis *vs* F0/1 fibrosis                Bacteroidetes\                                                          Bacteroidaceae[↑](#TFN2){ref-type="table-fn"}\                                                       *Bacteroides*[↑](#TFN2){ref-type="table-fn"}\                                                           
                                  F ≥ 2 fibrosis with NASH                                                             25                                                     Bacteroidetes\                                                          Prevotellaceae[↓](#TFN3){ref-type="table-fn"}\                                                       *Prevotella* [↓](#TFN3){ref-type="table-fn"}\                                                           
                                                                                                                                                                              Firmicutes\                                                             Ruminococcaceae\                                                                                     *Ruminococcus*[↑](#TFN2){ref-type="table-fn"}\                                                          
                                                                                                                                                                              Firmicutes                                                              Erysipelotrichaceae[↓](#TFN3){ref-type="table-fn"}                                                   N/A                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Mouzaki *et al.*^[@R17]^        Steatosis patients\                                                                  11\   NASH *vs* Healthy\                               Bacteroidetes [↓](#TFN3){ref-type="table-fn"}\                          N/A\                                                                                                 N/A\                                                                                                    Quantitative real-time PCR (Stool sample)
                                  NASH patients\                                                                       22\   NASH *vs* Steatosis                              Bacteroidetes [↓](#TFN3){ref-type="table-fn"}\                          N/A\                                                                                                 N/A\                                                                                                    
                                  Healthy controls                                                                     17                                                     Firmicutes                                                              Lachnospiraceae                                                                                      *Clostridium coccoides*[↑](#TFN2){ref-type="table-fn"}                                                  

                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Shen *et al*.^[@R18]^           NAFLD patients\                                                                      25\   NAFLD *vs* Healthy                               Proteobacteria [↑](#TFN2){ref-type="table-fn"}\                         Enterobacteriaceae[↑](#TFN2){ref-type="table-fn"}\                                                   *Escherichia_Shigella* [↑](#TFN2){ref-type="table-fn"}\                                                 16S rDNAamplicon sequencing (Stool sample)
                                  \                                                                                    \                                                      \                                                                       \                                                                                                    \                                                                                                       
                                  Healthy controls                                                                     22                                                     Fusobacteria [↑](#TFN2){ref-type="table-fn"}\                           N/A\                                                                                                 N/A\                                                                                                    
                                                                                                                                                                              Firmicutes\                                                             Lachnospiraceae [↑](#TFN2){ref-type="table-fn"}\                                                     *Lachnospiraceae_Incenae_Sedis*\                                                                        
                                                                                                                                                                              \                                                                       \                                                                                                    [↑](#TFN2){ref-type="table-fn"}, *Blautia*[↑](#TFN2){ref-type="table-fn"}\                              
                                                                                                                                                                              Firmicutes\                                                             Erysipelotrichaceae [↑](#TFN2){ref-type="table-fn"}\                                                 *Clostridium_XVIII* [↑](#TFN2){ref-type="table-fn"}\                                                    
                                                                                                                                                                              Firmicutes\                                                             Streptococcaceae[↑](#TFN2){ref-type="table-fn"}\                                                     *Streptococcus*[↑](#TFN2){ref-type="table-fn"}\                                                         
                                                                                                                                                                              Bacteroidetes[↓](#TFN3){ref-type="table-fn"}                            Prevotellaceae ↓                                                                                     *Prevotella* [↓](#TFN3){ref-type="table-fn"}                                                            

                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

                                  NAFLD patients with NASH\                                                            6\    NASH *vs* no NASH\                               Firmicutes\                                                             Lachnospiraceae [↑](#TFN2){ref-type="table-fn"}\                                                     *Blautia* [↑](#TFN2){ref-type="table-fn"}\                                                              
                                  NAFLD patients with fibrosis(F≥2)                                                    4     F ≥ 2 fibrosis *vs* F0/F1 fibrosis               Protenbacteria                                                          Enterobacteriaceae [↑](#TFN2){ref-type="table-fn"}                                                   *Escherichia_Shigella* [↑](#TFN2){ref-type="table-fn"}                                                  

                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Wang *et al*.^[@R19]^           NAFLD patients\                                                                      43\   NAFLD *vs* Healthy                               Bacteroidetes [↑](#TFN2){ref-type="table-fn"}\                          N/A\                                                                                                 N/A\                                                                                                    454 pyrosequencing of thel6S rRNA V3 region (Stool sample)
                                  \                                                                                    \                                                      \                                                                       \                                                                                                    \                                                                                                       
                                  Healthy controls                                                                     83                                                     Firmicutes [↓](#TFN3){ref-type="table-fn"}\                             Lachnospiraceae [↑](#TFN2){ref-type="table-fn"}\                                                     N/A\                                                                                                    
                                                                                                                                                                              Proteobacteria (Gramnegative bacteria[↑](#TFN2){ref-type="table-fn"})   Enterobacteriales                                                                                    *Escherichia_Shigella* [↑](#TFN2){ref-type="table-fn"}                                                  

                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Stanislawski *et al.*^[@R20]^   Adolescents exposure to gestational diabetes mellitus during singleton pregnancies   107    HFF *vs* non HFF                                Proteobacteria\                                                         Desulfovibrionaceae\                                                                                 *Bilophila*[↑](#TFN2){ref-type="table-fn"}\                                                             16S rRNA gene sequencing (Stool sample)
                                                                                                                                                                              \                                                                       \                                                                                                    \                                                                                                       
                                                                                                                                                                              Bacteroidetes\                                                          Prevotellaceae\                                                                                      *Paraprevotella* [↑](#TFN2){ref-type="table-fn"}\                                                       
                                                                                                                                                                              \                                                                       \                                                                                                    *Suturella* [↑](#TFN2){ref-type="table-fn"}\                                                            
                                                                                                                                                                              Proteobacteria\                                                         RF32\                                                                                                *RF32*[↑](#TFN2){ref-type="table-fn"}\                                                                  
                                                                                                                                                                              Bacteroidetes\                                                          Bacteroidaceae\                                                                                      *Bacteroides* (U-shaped pattern; [↑](#TFN2){ref-type="table-fn"} or [↓](#TFN3){ref-type="table-fn"})\   
                                                                                                                                                                              \                                                                       \                                                                                                    *oscillospira* [↓](#TFN3){ref-type="table-fn"}                                                          
                                                                                                                                                                              Firmicutes                                                              Ruminococcaceae                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Del Chierico *et al*.^[@R21]^   NAFLD patients                                                                       61    NAFLD *vs* Healthy                               Proteobacteria                                                          Bradyrhizobiaceae                                                                                    *Bradyrhizobium* [↑](#TFN2){ref-type="table-fn"}                                                        454 pyrosequencing of the16S rRNA V1-V3 region (Stool sample)

                                  Healthy controls                                                                     54                                                     Firmicutes\                                                             unassigned\                                                                                          *Anaerococcust* [↑](#TFN2){ref-type="table-fn"}\                                                        
                                                                                                                                                                              Firmicutes\                                                             unassigned\                                                                                          *Peptoniphilus*[↑](#TFN2){ref-type="table-fn"}\                                                         
                                                                                                                                                                              Actinobacteria\                                                         Propionibacteriaceae\                                                                                *Propionibacterium acnes*[↑](#TFN2){ref-type="table-fn"}\                                               
                                                                                                                                                                              Firmicutes\                                                             Lachnospiraceae\                                                                                     *Dorea* [↑](#TFN2){ref-type="table-fn"}\                                                                
                                                                                                                                                                              Firmicutes\                                                             Ruminococcaceae\                                                                                     *Ruminococcus*[↑](#TFN2){ref-type="table-fn"}\                                                          
                                                                                                                                                                              Firmicutes\                                                             Ruminococcaceae\                                                                                     *oscillospira*[↑](#TFN2){ref-type="table-fn"}\                                                          
                                                                                                                                                                              Bacteroidetes                                                           Rikenellaceae                                                                                        *Rikenellaceae* [↓](#TFN3){ref-type="table-fn"}                                                         

                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Zhu *et al.*^[@R22]^            NASH patients                                                                        22    NASH or Obese *vs* Healthy                       Actinobacteria [↓](#TFN3){ref-type="table-fn"}                          Bifidobacteriaceae [↓](#TFN3){ref-type="table-fn"}                                                   *Bifidobacterium* [↓](#TFN3){ref-type="table-fn"}                                                       16S rRNA pyrosequencing (Stool sample)

                                  Obese patients                                                                       25                                                     Bacteroidetes[↑](#TFN2){ref-type="table-fn"}                            Bactemidaceae (−)                                                                                    *Bacteroides* (−)                                                                                       

                                  Healthy controls                                                                     16                                                     Bacteroidetes[↑](#TFN2){ref-type="table-fn"}\                           Porphyromonadaceae (−)\                                                                              *Parabacteroides* (−)\                                                                                  
                                                                                                                                                                              Bacteroidetes[↑](#TFN2){ref-type="table-fn"}\                           Porphyromonadaceae\                                                                                  *Porphyromonas (−)*\                                                                                    
                                                                                                                                                                              Bacteroidetes [↑](#TFN2){ref-type="table-fn"}\                          Prevotellaceae [↑](#TFN2){ref-type="table-fn"}\                                                      *Prevotella* [↑](#TFN2){ref-type="table-fn"}\                                                           
                                                                                                                                                                              Bacteroidetes[↑](#TFN2){ref-type="table-fn"}\                           Rikenellaceae [↑](#TFN2){ref-type="table-fn"}\                                                       *Alistipes*[↑](#TFN2){ref-type="table-fn"}\                                                             
                                                                                                                                                                              Firmicutes [↓](#TFN3){ref-type="table-fn"}\                             Clostridiales family XI (−)\                                                                         *Anaerococcus* (−)\                                                                                     
                                                                                                                                                                              Firmicutes [↓](#TFN3){ref-type="table-fn"}\                             Peptoniphilaceae\                                                                                    *Finegoldia* (−)\                                                                                       
                                                                                                                                                                              Firmicutes [↓](#TFN3){ref-type="table-fn"}\                             Peptoniphilaceae\                                                                                    *Peptoniphilus* ↑\                                                                                      
                                                                                                                                                                              Firmicutes [↓](#TFN3){ref-type="table-fn"}\                             Lachnospiraceae [↓](#TFN3){ref-type="table-fn"}\                                                     *Blautia* [↓](#TFN3){ref-type="table-fn"}\                                                              
                                                                                                                                                                              Firmicutes [↓](#TFN3){ref-type="table-fn"}\                             Clostridiaceae\                                                                                      *Closm'dlum (−)*\                                                                                       
                                                                                                                                                                              Firmicutes [↓](#TFN3){ref-type="table-fn"}\                             Lachnospiraceae\                                                                                     *Coprococcus*[↓](#TFN3){ref-type="table-fn"}\                                                           
                                                                                                                                                                              Firmicutes [↓](#TFN3){ref-type="table-fn"}\                             Eubacteriaceae\                                                                                      *Eubacteriutnm*[↓](#TFN3){ref-type="table-fn"}\                                                         
                                                                                                                                                                              Firmicutes [↓](#TFN3){ref-type="table-fn"}\                             Lachnospiraceae\                                                                                     *Roseburia*[↓](#TFN3){ref-type="table-fn"}\                                                             
                                                                                                                                                                              Firmicutes[↓](#TFN3){ref-type="table-fn"}\                              Ruminococcaceae\                                                                                     *Ruminococcus (−)*\                                                                                     
                                                                                                                                                                              Firmicutes[↓](#TFN3){ref-type="table-fn"}\                              Ruminococcaceae [↓](#TFN3){ref-type="table-fn"}\                                                     *Faecalibacterium (−1)*\                                                                                
                                                                                                                                                                              Firmicutes [↓](#TFN3){ref-type="table-fn"}\                             Clostridiaceae\                                                                                      *Oscillospira* [↓](#TFN3){ref-type="table-fn"}\                                                         
                                                                                                                                                                              Firmicutes [↓](#TFN3){ref-type="table-fn"}\                             Ruminococcaceae\                                                                                     *Ruminococcus* [↓](#TFN3){ref-type="table-fn"}\                                                         
                                                                                                                                                                              Firmicutes [↓](#TFN3){ref-type="table-fn"}\                             Veillonellaceae (-}\                                                                                 *Acidaminococcus (−)*\                                                                                  
                                                                                                                                                                              Firmicutes[↓](#TFN3){ref-type="table-fn"}\                              Veillonellaceae (−)\                                                                                 *Dialister* (−)\                                                                                        
                                                                                                                                                                              Firmicutes [↓](#TFN3){ref-type="table-fn"}\                             Veillonellaceae (−)\                                                                                 *Megamonas* (−)\                                                                                        
                                                                                                                                                                              Proteobacteria [↓](#TFN3){ref-type="table-fn"}\                         Alcaligenaceae[↓](#TFN3){ref-type="table-fn"}\                                                       N/A\                                                                                                    
                                                                                                                                                                              Proteobacteria [↓](#TFN3){ref-type="table-fn"}\                         Campylobacteraceae (−)\                                                                              *Campylobacter* (−)\                                                                                    
                                                                                                                                                                              Proteobacteria [↓](#TFN3){ref-type="table-fn"}                          Enterobacteriaceae[↑](#TFN2){ref-type="table-fn"}                                                    *Escherichia* [↑](#TFN2){ref-type="table-fn"}                                                           

                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Koniffkoff *et al*.^[@R23]^     Mild/moderate NAFLD (Stage 0--2 fibrosis)                                            72    Stage 0--2 fibrosis *vs* Stage 3 or 4 fibrosis   Proteobacteria [↑](#TFN2){ref-type="table-fn"}                          N/A                                                                                                  N/A                                                                                                     Whole genome shotgun sequencing of DNA (Stool sample)

                                  Advanced fibrosis (Stage 3 or 4 fibrosis)                                            14                                                     Firmicutes [↓](#TFN3){ref-type="table-fn"}                              Eubacteriaceae                                                                                       *Eubacteriutn rectale* [↓](#TFN3){ref-type="table-fn"}                                                  

                                                                                                                                                                              Firmicutes [↓](#TFN3){ref-type="table-fn"}                              Ruminococcaceae                                                                                      *Ruminococcus obeum* CAG:39[↓](#TFN3){ref-type="table-fn"},\                                            
                                                                                                                                                                                                                                                                                                                                                           *Ruminococcus obeum* [↓](#TFN3){ref-type="table-fn"}                                                    

                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Roma *et al.*^[@R24]^           NAFLD                                                                                30    NAFLD *vs* Healthy                               Proteobacteria                                                          Kiloniellaceae [↑](#TFN2){ref-type="table-fn"}                                                       N/A                                                                                                     16S rRNA gene pyrosequencing (Stool sampie)

                                  Healthy controls                                                                     30                                                     Proteobacteria\                                                         Pasteurellaceae[↑](#TFN2){ref-type="table-fn"}\                                                      N/A\                                                                                                    
                                                                                                                                                                              Firmicutes\                                                             Lactobacillaceae [↑](#TFN2){ref-type="table-fn"}\                                                    *Lactobacillus*[↑](#TFN2){ref-type="table-fn"}\                                                         
                                                                                                                                                                              Firmicutes                                                              Lachnospiraceae [↑](#TFN2){ref-type="table-fn"}                                                      *Robinsoniella* [↑](#TFN2){ref-type="table-fn"},*Roseburia*[↑](#TFN2){ref-type="table-fn"},\            
                                                                                                                                                                                                                                                                                                                                                           *Dorea* [↑](#TFN2){ref-type="table-fn"}                                                                 

                                                                                                                                                                              Firmicutes\                                                             Ruminococcaceae [↓](#TFN3){ref-type="table-fn"}\                                                     *Oscillibacter*[↓](#TFN3){ref-type="table-fn"}\                                                         
                                                                                                                                                                              Firmicutes\                                                             Veillonellaceae [↑](#TFN2){ref-type="table-fn"} Porphyromonadaceae [↓](#TFN3){ref-type="table-fn"}   N/A\                                                                                                    
                                                                                                                                                                              Bacteroidetes                                                                                                                                                                N/A                                                                                                     
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Comparison of condition A *vs* condition B:

signifies an increase in condition A relative to condition B.

signifies a decrease in condition A relative to condition B.

(−) signifies no changes in condition A relative to condition B.

Abbreviations: NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; HFF, hepatic fat fraction; N/A, not applicable.

###### 

Gut microbiota alteration in cirrhotic patients.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors                     Population                                                      *N*              Comparison                           Implicated microbiota                             Methodology                                                                                                                                                                                                                                                       
  --------------------------- --------------------------------------------------------------- ---------------- ------------------------------------ ------------------------------------------------- ------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------
  Chen *et al*.^[@R34]^       Cirrhotic patients with HBV                                     24               Cirrhosis *vs* Healthy               Actinobacteria\                                   Coriobacteriaceae\                                                                                      *Atopobium*[↑](#TFN5){ref-type="table-fn"}\                                                                                                               16S rRNA gene pyrosequencing (Mucosa of the distal duodenum sample)
                                                                                                                                                    Firmicutes                                        Veillonellaceae                                                                                         *Dialister*[↑](#TFN5){ref-type="table-fn"}, *Veillonella*[↑](#TFN5){ref-type="table-fn"} and *Megasphera*[↑](#TFN5){ref-type="table-fn"}                  

                              Cirrhotic patients with PBC                                     6                                                     Proteobacteria                                    Pasteurellaceae                                                                                         *Hemophilus*[↓](#TFN6){ref-type="table-fn"}, *Neisseria*[↓](#TFN6){ref-type="table-fn"} and *SR 1 genera incertae sedis*[↓](#TFN6){ref-type="table-fn"}   

                              Healthy controls                                                28                                                                                                                                                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Bajaj *et al*.^[@R56]^      Patients with liver cirrhosis                                   219              Cirrhosis *vs* Healthy               Firmicutes                                        Lachnospiraceae[↓](#TFN6){ref-type="table-fn"},\                                                        N/A                                                                                                                                                       Multi-tagged pyrosequencing (Stool sample)
                                                                                                                                                                                                      Ruminococcaceae[↓](#TFN6){ref-type="table-fn"} and Clostridiales XIV [↓](#TFN6){ref-type="table-fn"},                                                                                                                                                             

                              Healthy controls                                                25                                                    Firmicutes                                        Staphylococcaceae [↑](#TFN5){ref-type="table-fn"},\                                                     N/A                                                                                                                                                       
                                                                                                                                                                                                      Enterococcaceae [↑](#TFN5){ref-type="table-fn"}                                                                                                                                                                                                                   

                                                                                                                                                    Proteobacteria\                                   Enterobacteriaceae[↑](#TFN5){ref-type="table-fn"}\                                                      N/A\                                                                                                                                                      
                                                                                                                                                    Firmicutes\                                       Veillonellaceae [↓](#TFN6){ref-type="table-fn"},\                                                       N/A                                                                                                                                                       
                                                                                                                                                    Bacteroidetes                                     Porphyromonadaceae [↓](#TFN6){ref-type="table-fn"}                                                                                                                                                                                                                

                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Bajaj *et al*.^[@R57]^      Patients with liver cirrhosis                                   278 out of 335   Hospitalized *vs* non Hospitalized   Bacteroidetes                                     Bacteroidaceae [↓](#TFN6){ref-type="table-fn"}                                                          N/A                                                                                                                                                       16S rRNA pyrosequencing (Stool sample)

                              Non hospitalized patients with liver cirrhosis within 90 days   162                                                   Firmicutes                                        Clostridiales XIV[↓](#TFN6){ref-type="table-fn"},\                                                      N/A                                                                                                                                                       
                                                                                                                                                                                                      Lachnospiraceae[↓](#TFN6){ref-type="table-fn"},\                                                                                                                                                                                                                  
                                                                                                                                                                                                      Ruminococcacae[↓](#TFN6){ref-type="table-fn"}                                                                                                                                                                                                                     

                                                                                                                                                    Firmicutes\                                       Enterococcaceae[↓](#TFN6){ref-type="table-fn"}\                                                         N/A\                                                                                                                                                      
                                                                                                                                                    Proteobacteria                                    Enterobacteriaceae [↓](#TFN6){ref-type="table-fn"}                                                      N/A                                                                                                                                                       

                              Hospitalized patients with liver cirrhosis                      94                                                    Bacteroidetes [↓](#TFN6){ref-type="table-fn"}     BacterDidetes_Bacteroidaceae [↓](#TFN6){ref-type="table-fn"},                                           N/A                                                                                                                                                       

                                                                                                                                                    Bacteroidetes[↓](#TFN6){ref-type="table-fn"}      Bacteroidetes_Porphyromonadaceae [↓](#TFN6){ref-type="table-fn"}                                        N/A                                                                                                                                                       

                                                                                                                                                    Firmicutes\                                       Firmicutes_Lactobacillaceae [↑](#TFN5){ref-type="table-fn"}\                                            N/A\                                                                                                                                                      
                                                                                                                                                    Firmicutes\                                       Firmicutes_Enterococcaceae [↑](#TFN5){ref-type="table-fn"}\                                             N/A\                                                                                                                                                      
                                                                                                                                                    Firmicutes\                                       Firmicutes_Clostridiales XIV[↓](#TFN6){ref-type="table-fn"}\                                            N/A\                                                                                                                                                      
                                                                                                                                                    Firmicutes\                                       Firmicutes_Lachnospiraceae [↓](#TFN6){ref-type="table-fn"}\                                             N/A\                                                                                                                                                      
                                                                                                                                                    Firmicutes\                                       Firmicutes_Ruminococcaceae [↓](#TFN6){ref-type="table-fn"}\                                             N/A\                                                                                                                                                      
                                                                                                                                                    Proteobacteria\                                   Proteobacteria-Enterobacteriaceae[↑](#TFN5){ref-type="table-fn"}\                                       N/A\                                                                                                                                                      
                                                                                                                                                    Proteobacteria                                    Proteobacteria_Pasteurellaceae [↑](#TFN5){ref-type="table-fn"}                                          N/A\                                                                                                                                                      
                                                                                                                                                                                                                                                                                                              N/A                                                                                                                                                       

                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

                              Non DM                                                          191              DM *vs* non DM                       Bacteroidetes                                     Bacteroidetes_Bacteroidaceae [↓](#TFN6){ref-type="table-fn"}                                            N/A                                                                                                                                                       

                              DM                                                              87                                                    Proteobacteria\                                   Firmicutes_Eubacteriaceae [↓](#TFN6){ref-type="table-fn"}\                                              N/A\                                                                                                                                                      Mucosal sample
                                                                                                                                                    Firmicutes\                                       Firmicutes_Ruminococcaceae [↑](#TFN5){ref-type="table-fn"}\                                             N/A\                                                                                                                                                      
                                                                                                                                                    Firmicutes\                                       Firmicutes_VeilIonellaceae[↓](#TFN6){ref-type="table-fn"}\                                              N/A\                                                                                                                                                      
                                                                                                                                                    Firmicutes\                                       Firmicutes_Streptococcaceae[↓](#TFN6){ref-type="table-fn"}\                                             N/A\                                                                                                                                                      
                                                                                                                                                    Actinobacteria                                    Actinobacteria_Streptomycetae [↓](#TFN6){ref-type="table-fn"}                                           N/A                                                                                                                                                       

                                                                                                                                                    Firmicutes\                                       Firmicutes_Clostridiacaeae [↓](#TFN6){ref-type="table-fn"}\                                             N/A\                                                                                                                                                      
                                                                                                                                                    Bacteroidetes\                                    Bacteroidetes_Prevotellaceae [↑](#TFN5){ref-type="table-fn"}\                                           N/A\                                                                                                                                                      
                                                                                                                                                    Fusobacteria                                      Fusobacteria_Fusobacteriaceae [↑](#TFN5){ref-type="table-fn"}                                           N/A                                                                                                                                                       

                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Chen *et al*.^[@R59]^       Patients with liver cirrhosis\                                  36\              Cirrhosis *vs* Healthy               Bacteroidetes[↓](#TFN6){ref-type="table-fn"}\     Enterobacteriaceae [↑](#TFN5){ref-type="table-fn"}\                                                     N/A\                                                                                                                                                      The 16S rRNA V3 region pyrosequencing;\
                              Healthy controls                                                24                                                    Proteobacteria [↓](#TFN6){ref-type="table-fn"}\   N/A\                                                                                                    N/A\                                                                                                                                                      Real-time PCR (Stool sample)
                                                                                                                                                    Fusobacteria[↓](#TFN6){ref-type="table-fn"}\      N/A\                                                                                                    N/A\                                                                                                                                                      
                                                                                                                                                    Firmicutes\                                       Veillonellaceae[↑](#TFN5){ref-type="table-fn"}\                                                         N/A\                                                                                                                                                      
                                                                                                                                                    Firraicutes\                                      Streptococcaceae[↑](#TFN5){ref-type="table-fn"}\                                                        N/A\                                                                                                                                                      
                                                                                                                                                    Firmicutes                                        Lachnospiraceae[↓](#TFN6){ref-type="table-fn"}                                                          *Coprococcus* [↓](#TFN6){ref-type="table-fn"}, *Pseudobutyrivibrio* [↓](#TFN6){ref-type="table-fn"}\                                                      
                                                                                                                                                                                                                                                                                                              *Roseburia* [↓](#TFN6){ref-type="table-fn"}                                                                                                               

                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Kakiyama *et al*.^[@R64]^   Early cirrhotics                                                23               Cirrhosis *vs* Healthy               Firmicutes                                        Lachonospiraceae[↓](#TFN6){ref-type="table-fn"},\                                                       N/A                                                                                                                                                       Culture-independent multitagged-pyrosequencing (Stool sample)
                                                                                                                                                                                                      Ruminococcaceae [↓](#TFN6){ref-type="table-fn"}                                                                                                                                                                                                                   

                                                                                                                                                    Firmicutes                                        Lachnospiraceae                                                                                         *Blautia* [↓](#TFN6){ref-type="table-fn"}                                                                                                                 

                              Advanced cirrhotics                                             24                                                    Bacteroidetes                                     Rikenellaceae[↓](#TFN6){ref-type="table-fn"}                                                            N/A                                                                                                                                                       

                              Healthy controls                                                14                                                    Proteobacteria                                    Enterobacteriaceae [↑](#TFN5){ref-type="table-fn"}                                                      N/A                                                                                                                                                       
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Comparison of condition A *vs* condition B:

signifies an increase in condition A relative to condition B.

signifies a decrease in condition A relative to condition B.

Abbreviations: HBV, hepatitis B virus; PBC, primary biliary cirrhosis; DM, diabetes mellitus; N/A, not applicable.

###### 

Gut microbiota alteration and liver transplantation.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors                  Population                                                           *N*   Comparison                                     Implicated microbiota                                                                           Methodology                                                                                                                                                                                       
  ------------------------ -------------------------------------------------------------------- ----- ---------------------------------------------- ----------------------------------------------------------------------------------------------- ------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------
  Sun *et al*.^[@R79]^     Post-LT patients\                                                    9\    Post-LT *vs* Pre-LT                            Proteobacteria\                                                                                 Pasteurellaceae\                                       *Actinobacillus* [↓](#TFN9){ref-type="table-fn"}\                                                                                          MiSeq-PE250 sequencing of the V4 region of 16S rRNA (Stool sample)
                           \                                                                    \                                                    Proteobacteria\                                                                                 Enterobacteriaceae\                                    *Escherichia*[↓](#TFN9){ref-type="table-fn"} and *Shigella*[↓](#TFN9){ref-type="table-fn"}\                                                
                           Healthy controls                                                     15                                                   \                                                                                               \                                                      \                                                                                                                                          
                                                                                                                                                     Actinobacteria\                                                                                 Micromonosporaceae\                                    *Micromonosporaceae* [↑](#TFN8){ref-type="table-fn"}\                                                                                      
                                                                                                                                                     Proteobacteria\                                                                                 Desulfobacteraceae\                                    *Desulfobacterales* [↑](#TFN8){ref-type="table-fn"}\                                                                                       
                                                                                                                                                     Proteobacteria\                                                                                 Eubacteriaceae\                                        *the Sarcina genus of Eubacteriaceae* [↑](#TFN8){ref-type="table-fn"}\                                                                     
                                                                                                                                                     Verrucomicrobia                                                                                 Akkermansiaceae                                        *Akkermansia* [↑](#TFN8){ref-type="table-fn"}                                                                                              

                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Bajaj *et al*.^[@R80]^   Outpatient patients with cirrhosis on the LT list Healthy controls   45\   Improved cognition post-LT *vs* Pre-LT         Proteobacteria [↓](#TFN9){ref-type="table-fn"} and Firmicutes [↑](#TFN8){ref-type="table-fn"}   N/A                                                    N/A                                                                                                                                        Multitagged sequencing; 16s rRNA (V1-V2) sequencing (Stool sample)
                                                                                                45                                                                                                                                                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                                                                                                       

                                                                                                      Not improved cognition after LT *vs* Healthy   Proteobacteria [↑](#TFN8){ref-type="table-fn"} and Firmicutes [↓](#TFN9){ref-type="table-fn"}   N/A                                                    N/A                                                                                                                                        

                                                                                                      post-LT *vs* Pre-LT                            Firmicutes (−)                                                                                  Ruminococcaceae [↑](#TFN8){ref-type="table-fn"} and\   N/A                                                                                                                                        
                                                                                                                                                                                                                                                     Lachnospiraceae [↑](#TFN8){ref-type="table-fn"}                                                                                                                                                   

                                                                                                                                                     Bacteroidetes (−)                                                                               N/A                                                    N/A                                                                                                                                        

                                                                                                                                                     Proteobacteria (−)                                                                              Enterobacteriaceae                                     Escherichia [↓](#TFN9){ref-type="table-fn"}, *Salmonella*[↓](#TFN9){ref-type="table-fn"} and *Shigella* [↓](#TFN9){ref-type="table-fn"}    

                                                                                                                                                                                                                                                                                                                                                                                                                                                       

                                                                                                      Pre-LT patients *vs* Healthy\                  Proteobacteria (−)\                                                                             Enterobacteriaceae\                                    *Escherichia*, [↑](#TFN8){ref-type="table-fn"} *Shigella*, [↑](#TFN8){ref-type="table-fn"} *Salmonella* [↑](#TFN8){ref-type="table-fn"}\   
                                                                                                      Post-LT patients *vs* Healthy                  Firmicutes (−)\                                                                                 Ruminococcaceae [↑](#TFN8){ref-type="table-fn"} and\   N/A\                                                                                                                                       
                                                                                                                                                     \                                                                                               Lachnospiraceae [↑](#TFN8){ref-type="table-fn"}\       \                                                                                                                                          
                                                                                                                                                     Actinobacteria\                                                                                 Bifidobacteriaceae [↓](#TFN9){ref-type="table-fn"}\    N/A\                                                                                                                                       
                                                                                                                                                     Bacteroidetes                                                                                   Bacteroidaceae[↑](#TFN8){ref-type="table-fn"}          N/A                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Bajaj *et al*.^[@R81]^   Patients with cirrhosis                                              40    Post-LT *vs* Pre-LT                            Proteobacteria\                                                                                 Enterobacteriaceae\                                    *Shigella*[↓](#TFN9){ref-type="table-fn"}*, Escherichia* [↓](#TFN9){ref-type="table-fn"}, and\                                             Multitagged sequencing (Stool sample)
                                                                                                                                                     \                                                                                               \                                                      *Salmone*[↓](#TFN9){ref-type="table-fn"}\                                                                                                  
                                                                                                                                                     Proteobacteria\                                                                                 Sutterellaceae\                                        *Suterella* [↑](#TFN8){ref-type="table-fn"}\                                                                                               
                                                                                                                                                     Proteobacteria\                                                                                 Desulfovibrionales\                                    *Bilophila*[↑](#TFN8){ref-type="table-fn"}\                                                                                                
                                                                                                                                                     Actinobacteria\                                                                                 Bifidobacteriaceae\                                    *Bifidobacterium* [↓](#TFN9){ref-type="table-fn"}\                                                                                         
                                                                                                                                                     Firmicutes\                                                                                     Clostridiales Incertae Sedis XI\                       *Desulfatibacter* [↑](#TFN8){ref-type="table-fn"}, and\                                                                                    
                                                                                                                                                     \                                                                                               \                                                      *Sporanaerobacter*[↑](#TFN8){ref-type="table-fn"}\                                                                                         
                                                                                                                                                     \                                                                                               Ruminococcaceae\                                       *ClostridiumlV*[↑](#TFN8){ref-type="table-fn"}, *Osdiiibocte*[↑](#TFN8){ref-type="table-fn"},\                                             
                                                                                                                                                     \                                                                                               Clostridiales Incertae Sedis XIII\                     *Anaerovorax* [↑](#TFN8){ref-type="table-fn"}\                                                                                             
                                                                                                                                                     Firmicutes\                                                                                     Lachnospiraceae\                                       *Anaerostipes*[↑](#TFN8){ref-type="table-fn"}*, Clostridium XIVb* [↑](#TFN8){ref-type="table-fn"},\                                        
                                                                                                                                                     Firmicutes\                                                                                     \                                                      *Blautia*[↑](#TFN8){ref-type="table-fn"} *Roseburia*[↑](#TFN8){ref-type="table-fn"}, and *Dorea*[↑](#TFN8){ref-type="table-fn"}\           
                                                                                                                                                     Firmicutes\                                                                                     Streptococcaceae\                                      *Streptococcus*[↑](#TFN8){ref-type="table-fn"}\                                                                                            
                                                                                                                                                     \                                                                                               Clostridiaceae\                                        *Butyricicoccus*[↑](#TFN8){ref-type="table-fn"}, *CtostridiumXIVa* [↑](#TFN8){ref-type="table-fn"}\                                        
                                                                                                                                                     Firmicutes\                                                                                     Rikenellaceae                                          *Alistipes*[↑](#TFN8){ref-type="table-fn"}                                                                                                 
                                                                                                                                                     Firmicutes\                                                                                                                                                                                                                                                                                       
                                                                                                                                                     Bacteroidetes                                                                                                                                                                                                                                                                                     
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Comparison of condition A **vs** condition B:

signifies an increase in condition A relative to condition B.

signifies a decrease in condition A relative to condition B.

(−) signifies no changes in condition A relative to condition B.

Abbreviations: LT, liver transplantation; N/A, not applicable.

###### 

Fungal dysbiosis in complications associated with liver cirrhosis.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors                  Population                                *N*   Comparison                                  Implicated microbiota                            Methodology                                                                                                    
  ------------------------ ----------------------------------------- ----- ------------------------------------------- ------------------------------------------------ ------------------------------------------------------------------ ------------------------------------------- --------------------------------------------------------
  Bajaj *et al*.^[@R85]^   Outpatients cirrhotics                    77    Inpatients *vs* Outpatients                 Basidiomycota[↓](#TFN12){ref-type="table-fn"}\   Bacteroidetes/Ascomycota ratio [↑](#TFN11){ref-type="table-fn"}\   N/A\                                        Metagenomics (Stool sample)
                                                                                                                       Ascomycota                                       Saccharomycetaceae                                                 *Candida*[↑](#TFN11){ref-type="table-fn"}   

                           Inpatients cirrhotics                     66    After antibiotics *vs* before antibiotics   Ascomycota                                       Saccharomycetaceae                                                 *Candida*[↑](#TFN11){ref-type="table-fn"}   

                           Controls                                  26    Inpatients *vs* Outpatients                 Ascomycota                                       Saccharomycetaceae                                                 *Candida*[↑](#TFN11){ref-type="table-fn"}   

                                                                                                                       Proteobacteria                                   Enterobacteriaceae[↑](#TFN11){ref-type="table-fn"}                 N/A                                         

                                                                                                                       Firmicutes                                       Enterococcaceae[↑](#TFN11){ref-type="table-fn"}                    N/A                                         

                                                                           Outpatients *vs* Controls                   Basidiomycota[↓](#TFN12){ref-type="table-fn"}    N/A                                                                N/A                                         

                                                                                                                       Ascomycota                                       Saccharomycetaceae                                                 *Candida*[↑](#TFN11){ref-type="table-fn"}   

                                                                           Inpatients *vs* Controls                    Proteobacteria                                   Enterobacteriaceae [↑](#TFN11){ref-type="table-fn"}                N/A                                         

                                                                                                                       Firmicutes                                       Enterococcaceae[↑](#TFN11){ref-type="table-fn"}                    N/A                                         

                                                                           Outpatients on antibiotics                  Ascomycota [↑](#TFN11){ref-type="table-fn"}      Saccharomycetaceae                                                 *Candida*[↑](#TFN11){ref-type="table-fn"}   

                                                                                                                       Proteobacteria                                   Pasteurellaceae[↑](#TFN11){ref-type="table-fn"}                    N/A                                         

                                                                                                                                                                                                                                                                                       

  Yang *et al*.^[@R86]^    Healthy individuals                       8     Patients *vs* Healthy individuals           Ascomycota                                       Saccharomycetaceae                                                 *Candida*[↑](#TFN11){ref-type="table-fn"}   lllumina MiSeq platform

                           Alcohol-dependent                         10                                                                                                                                                                                                                sequencing of the V4 region of 16S rRNA (Stool sample)

                           patients (nonprogressive liver disease)                                                                                                                                                                                                                     

                           Patients with alcoholic liver cirrhosis   4                                                                                                                                                                                                                 
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Comparison of condition A *vs* condition B:

signifies an increase in condition A relative to condition B.

signifies a decrease in condition A relative to condition B.

Abbreviation: N/A, not applicable.

###### 

Oral microbiota alteration in patients with cirrhosis.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors                  Population                                 *N*   Comparison                                         Impiicated microbiota   Methodology                                                                                                                                                                                                                                             
  ------------------------ ------------------------------------------ ----- -------------------------------------------------- ----------------------- -------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------
  Chen *et al*.^[@R34]^    Cirrhotic patients                         30    Patients *vs* Controls                             Actinobacteria          Coriobacteriaceae                                                                                        *Atopobium*[↑](#TFN14){ref-type="table-fn"}                                                                                                    16S rRNA gene pyrosequencing

                                                                                                                               Firmicutes              Veillonellaceae                                                                                          *Dialister*[↑](#TFN14){ref-type="table-fn"}, *Veillonella*[↑](#TFN14){ref-type="table-fn"}, and *Megasphera*[↑](#TFN14){ref-type="table-fn"}   (Mucosal from the distal duodenum sample)

                           Healthy controls                           28                                                       Proteobacteria          Pasteurellaceae                                                                                          *Hemophilus* [↓](#TFN15){ref-type="table-fn"}                                                                                                  

                                                                                                                               Proteobacteria          Neisseriaceae                                                                                            *Neisseria* [↓](#TFN15){ref-type="table-fn"}                                                                                                   

                                                                                                                               undefined               undefined                                                                                                *SR 1 genera incertae sedis*[↓](#TFN15){ref-type="table-fn"}                                                                                   

                                                                                                                                                                                                                                                                                                                                                                                                               

  Qin *et al*.^[@R87]^     Patients with cirrhosis                    98    Patients *vs* Controls                             Firmicutes              Streptococcaceae                                                                                         *Streptococcus*[↑](#TFN14){ref-type="table-fn"}                                                                                                Quantitative metagenomics (Stool sample)

                                                                                                                               Firmicutes              Veillonellaceae                                                                                          *Veillonella* [↑](#TFN14){ref-type="table-fn"}                                                                                                 

                           Healthy controls                           83                                                       Firmicutes              Enterococcaceae [↑](#TFN14){ref-type="table-fn"}                                                         N/A                                                                                                                                            

                                                                                                                               Proteobacteria          Enterobacteriaceae[↑](#TFN14){ref-type="table-fn"}                                                       N/A                                                                                                                                            

                                                                                                                                                                                                                                                                                                                                                                                                               

  Bajaj *et al*.^[@R89]^   Patients with cirrhosis without HE         59    Patients *vs* Controls                             Bacteroidetes           Prevotellaceae                                                                                           *Prevotella* [↑](#TFN14){ref-type="table-fn"}                                                                                                  Quantitative metagenomics (Stool or saliva sample)

                                                                                                                               Fusobacteria            Fusobacteriaceae [↑](#TFN14){ref-type="table-fn"}                                                        N/A                                                                                                                                            

                           Patients with cirrhosis with previous HE   43                                                       Firmicutes              Lachnospiraceae [↓](#TFN15){ref-type="table-fn"} and                                                     N/A                                                                                                                                            

                                                                                                                                                       Ruminococcaceae [↓](#TFN15){ref-type="table-fn"}                                                                                                                                                                                                        

                           age-matched controls                       32                                                       Proteobacteria          Enterobacteriaceae[↑](#TFN14){ref-type="table-fn"}                                                       N/A                                                                                                                                            

                                                                                                                               Firmicutes              Enterococcaceae [↑](#TFN14){ref-type="table-fn"}                                                         N/A                                                                                                                                            

                                                                                                                                                                                                                                                                                                                                                                                                               

  Bajaj *et al*.^[@R90]^   Cirrhotic outpatients on PPI               59    PPI users *vs* Patients without PPI and Controls   Firmicutes              Streptococcaceae[↑](#TFN14){ref-type="table-fn"}                                                         N/A                                                                                                                                            Multi-tagged sequencing (Stool sample)

                                                                                                                               Firmicutes              Lachnospiraceae[↓](#TFN15){ref-type="table-fn"}                                                          N/A                                                                                                                                            

                           Cirrhotic outpatients not on PP1           78                                                                                                                                                                                                                                                                                                                                       

                           Healthy controls                           45                                                                                                                                                                                                                                                                                                                                       

                                                                                                                                                                                                                                                                                                                                                                                                               

                           Cirrhotic outpatients not on PPI           15    After *vs* Before PPI initiation                   Bacteroidetes\          Porphyromonadaceae [↑](#TFN14){ref-type="table-fn"}\                                                     N/A\                                                                                                                                           
                                                                                                                               Firmicutes              Streptococcaceae[↑](#TFN14){ref-type="table-fn"}                                                         N/A                                                                                                                                            

                                                                                                                                                                                                                                                                                                                                                                                                               

                           Patients with decompensated\               15    PPI withdrawal *vs* Pre-PPI therapy                Bacteroidetes           Porphyromonadaceae [↓](#TFN15){ref-type="table-fn"}                                                      N/A                                                                                                                                            
                           cirrhosis on chronic PPI                                                                                                                                                                                                                                                                                                                                                            

                                                                                                                               Firmicutes              Streptococcaceae [↓](#TFN15){ref-type="table-fn"}, and Veillonellaceae[↓](#TFN15){ref-type="table-fn"}   N/A                                                                                                                                            
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Comparison of condition A *vs* condition B:

signifies an increase in condition A relative to condition B.

signifies a decrease in condition A relative to condition B.

Abbreviations: HE, hepatic encephalopathy; PP1, proton pump inhibitors; N/A, not applicable.

###### 

Gut microbiota alteration in human HCC.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors                     Population                                                                               *N*   Comparison                                              Implicated microbiota   Methodology                                                                  
  --------------------------- ---------------------------------------------------------------------------------------- ----- ------------------------------------------------------- ----------------------- -------------------- ------------------------------------------------------- ----------------------------------------------------------------
  Nilsson *et al*. ^[@R95]^   Liver specimens of patients with cholangiocarcinoma\                                     14\   HCC or cholangiocarcinoma specimens *vs* Controls       Proteobacteria          Helicobacteraceae    *Helicobacter* spp.[↑](#TFN17){ref-type="table-fn"}     PCR and DNA sequencing (HCC human specimens)
                              HCC human specimens\                                                                     16\                                                                                                                                                                
                              Controls (liver tissue from patients with resected métastasés from colorectal cancers)   20                                                                                                                                                                 

  Huang *et al*.^[@R96]^      HCC human specimens\                                                                     20\   HCC specimens *vs* Controls                             Proteobacteria          Helicobacteraceae    *Helicobacter pylori*[↑](#TFN17){ref-type="table-fn"}   PCR, DNA sequencing, and immunostaining (Liver specimens)
                              Controls without HCC                                                                     16                                                                                                                                                                 

  Krüttgen *et al*.^[@R97]^   Patients with viral-induced HCC\                                                         14\   Patients with viral-induced HCC *vs* Control patients   Proteobacteria          Helicobacteraceae    *H. hepaticus* (no exist)                               PCR (Stool sample)
                              Control patients                                                                         11                                                                                                                                                                 

  Grat *et al*.^[@R99]^       Patients with HCC\                                                                       15\   HCC *vs* non HCC                                        Proteobacteria          Enterobacteriaceae   *Escherichia coli* [↑](#TFN17){ref-type="table-fn"}     Culturing on enriching and selective agar media (Stool sample)
                              Non HCC patients                                                                         15                                                                                                                                                                 

  Lu *et al*.^[@R104]^        Early liver carcinoma patients with cirrhosis\                                           35\   HCC *vs* Healthy                                        Firmicutes\             Lachnospiraceae\     *Oribacterium* changes\                                 16S rRNA gene sequencing (Tongue coat sample)
                              Healthy controls                                                                         25                                                            Fusobacteria            Fusobacteriaceae     *Fusobacterium* changes                                 
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Comparison of condition A **vs** condition B:

signifies an increase in condition A relative to condition B.

Abbreviation: HCC, hepatocellular carcinoma.

###### 

Gut microbiota alteration in HCC animal models.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors                           Model                           Agent                 Comparison                                                                                                                     Implicated microbiota   Methodology                                                                                                                                                                                                                                                 
  --------------------------------- ------------------------------- --------------------- ------------------------------------------------------------------------------------------------------------------------------ ----------------------- -------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------
  Xie *et al.*^[@R100]^             NASH-HCC C57BL/6J mouse model   STZ-HFD               NASH-HCC *vs* Controls                                                                                                         Actinobacteria\         Coriobacteriaceae\   *Atopobium* spp.[↑](#TFN19){ref-type="table-fn"}\                                                                                                                                                                                      16S rDNA gene pyrosequencing (Stool sample)
                                                                                                                                                                                                                         Bacteroidetes           Bacteroidaceae       *Bacteroides* spp. [↑](#TFN19){ref-type="table-fn"} *Bacteroides vulgcitus,*[↑](#TFN19){ref-type="table-fn"} *Bacteroides acidifaciens*[↑](#TFN19){ref-type="table-fn"} *and Bacteroides uniformis* [↑](#TFN19){ref-type="table-fn"}   

                                    Firmicutes                      Clostridiaceae        *Clostridium cocleatum*, [↑](#TFN19){ref-type="table-fn"} *Clostridium* and *xylanolyticum* [↑](#TFN19){ref-type="table-fn"}                                                                                                                                                                                                                                                                                       

                                    Proteobacteria                  Desulfovibrionaceae   *Desulfovibrio* spp.[↑](#TFN19){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                                               

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Zhang *et al.*^[@R101]^           Male Sprague-Dawley HCC rats    DEN                   HCC rats *vs* Controls                                                                                                         Firmicutes\             Lactobacillaceae\    *Lactobacillus* [↓](#TFN20){ref-type="table-fn"}\                                                                                                                                                                                      16S rRNA based quantitative real-time PCR (Stool sample)
                                                                                                                                                                                                                         Firmicutes\             Enterococcaceae\     *Enterococcus* [↓](#TFN20){ref-type="table-fn"}\                                                                                                                                                                                       
                                                                                                                                                                                                                         Actinobacteria          Bifidobacteriaceae   *Bifidobacterium* [↓](#TFN20){ref-type="table-fn"}                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Gómez-Hurtado *et al.*^[@R102]^   Female Balb/c fibrosis mice     CCI~4~                Fibrosis mice *vs* Controls                                                                                                    Firmicutes\             Clostridiaceae\      *Clostiidia* spp.[↓](#TFN20){ref-type="table-fn"}\                                                                                                                                                                                     Quantitative real-time PCR (Stool sample)
                                                                                                                                                                                                                         Firmicutes\             Clostridiaceae\      *Clostiidium coccoides* [↓](#TFN20){ref-type="table-fn"}\                                                                                                                                                                              
                                                                                                                                                                                                                         Firmicutes              Clostridiaceae       *Clostridium leptum* [↓](#TFN20){ref-type="table-fn"}                                                                                                                                                                                  
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Comparison of condition A **vs** condition B:

signifies an increase in condition A relative to condition B.

signifies a decrease in condition A relative to condition B.

Abbreviations: STZ-HFD, streptozotocin-high fat diet; DEN, diethylnitrosamine; HCC, hepatocellular carcinoma; CCL~4~ carbon tetrachloride.
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